Miller School Team Investigates Novel Shockwave Therapy for Erectile Dysfunction
Erectile dysfunction is a condition affecting as many as 30 million men in America — 50 percent of whom are over the age of 60. Despite its prevalence, there have been no major advances since the late 1990s. A team at the University of Miami Miller School of Medicine is the only group in the U.S. that is studying a promising new treatment – the low-intensity shockwave device Renova-Erectile Dysfunction (Renova-ED).
A linear shockwave device, Renova-ED incorporates a unique shockwave transducer to deliver short, incredibly fast bursts of energy to a targeted part of the body — in this case, the left and right corpora cavernosa and the crura, portions of penile tissue. It’s an acoustic wave therapy, similar to ultrasound.
The best candidates for this type of new therapy are men who have not tried any therapy medications, or those who have already tried Viagra or Cialis.
The FDA has already approved shockwave therapy to promote wound healing, and for the treatment of plantar fasciitis, Achilles tendonitis, and epicondylitis of the elbow. In 2010, linear shockwave therapy began being studied in the treatment of erectile dysfunction.
This form of shockwave therapy, however, is different from ESWL (Extracorporeal Shockwave Lithotripsy), commonly used to break up kidney stones. It uses a lower energy volume and can be focused on a more concentrated area to obtain better results.
For information about the shockwave therapy, call 305-243-6591.